CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.
Before the advent of biologics, commercialization of a therapeutic relied on successfully scaling up to meet market demand. This scaling-up strategy expanded biomanufacturing capacity by upsizing the ...
This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production. This innovative approach could ...
Wang tells PV Tech Premium that copper offers a ‘a compelling combination’ of traits to replace silver. Image: AIKO. This Premium article, which was one of the most read Premium articles in 2025, has ...
Tesla has completed an Iron LFP battery factory in Nevada. This is probably going to take 1-2 years to hit volume production and the rumor is that the initial production capacity is 10 GWh per year.
Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...
FREDERICK, Md. and PLANO, Texas, Oct. 6, 2025 /PRNewswire/ -- RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development ...
Five years ago, during 2020 Battery Day, Tesla unveiled the 4680 cells as the most advanced battery tech in the world. However, CEO Elon Musk now regrets he pursued the dry battery electrode process, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results